与阿尔茨海默病相关的局部特异性内源性逆转录病毒表达
Tyson Dawson1,2, Uzma Rentia1, Jessie Sanford3
1Computational Biology Institute, The George Washington University, Washington, DC, United States.
Frontiers in aging neuroscience
|July 24, 2023
概括
人体内源逆转录病毒 (HERVs) 与阿尔茨海默病有关. 阿尔茨海默病患者的失调的HERV表达和局部化模式可能会驱动病原性基因表达,为疾病机制提供新的见解.
科学领域:
- 基因组学就是基因组学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 人体内源逆转录病毒 (HERV) 是人类基因组中集成的古老逆转录病毒遗留物.
- 异常的HERV表达与各种疾病有关,包括神经系统疾病.
- 在阿尔茨海默病 (AD) 发病过程中HERVs的作用仍然不完全理解.
研究的目的:
- 为了研究阿尔茨海默病患者中HERVs的表达模式.
- 探索在AD中HERV表达和基因表达之间的相关性.
- 为了确定与疾病相关基因相关的差异表达HERVs的基因组定位.
主要方法:
- 结合了来自103名阿尔茨海默病患者和45名健康对照的两个公开和一个新型RNA-Seq数据集.
- 使用"望远镜"工具进行HERV量化和基因表达分析.
- 鉴定了差异表达的基因和HERV,并分析了它们的基因组近距离.
主要成果:
- 在AD患者和对照人群之间发现了基因和HERV表达的显著差异.
- 在整个基因组中发现了许多差异表达的HERV,其中许多属于HERV-K超级家族.
- 发现了特定的HERVs和参与AD途径的失调基因之间的相关性,这些基因通常位于身体附近.
结论:
- HERVs的失调表达是阿尔茨海默病的一个特征.
- 这些HERV的基因组定位表明了它们可能影响AD病原性基因表达的机制.
- 这些发现凸显了HERVs作为阿尔茨海默病病理学的潜在贡献者.
相关概念视频
01:26Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
01:22Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
03:08LTR Retrotransposons
17.6K
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
17.6K